Published in J Alzheimers Dis on January 01, 2012
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal (2013) 0.94
The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders. Front Pharmacol (2014) 0.91
The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin. Neurobiol Dis (2015) 0.81
Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J Neuroinflammation (2016) 0.77
Therapies for Prevention and Treatment of Alzheimer's Disease. Biomed Res Int (2016) 0.77
Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice. Int J Mol Sci (2016) 0.77
Vitamin E, Turmeric and Saffron in Treatment of Alzheimer's Disease. Antioxidants (Basel) (2016) 0.75
Regulating the fate of mRNA: the control of cellular iron metabolism. Cell (1993) 6.47
Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A (1996) 5.53
Iron-chelation therapy with oral deferipronein patients with thalassemia major. N Engl J Med (1995) 3.88
Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med (1997) 3.74
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J (1993) 3.51
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A (1997) 3.47
Regulation of ferritin and transferrin receptor mRNAs. J Biol Chem (1990) 2.74
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol (2010) 2.71
Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem (1991) 2.63
The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med (2002) 2.51
The metallobiology of Alzheimer's disease. Trends Neurosci (2003) 2.47
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell (2010) 2.46
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci (2005) 2.36
Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta (2006) 2.23
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem (1988) 2.15
An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem (2002) 2.00
Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci (2004) 1.91
Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A (1994) 1.91
Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry (1999) 1.88
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J (1994) 1.85
Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol (2011) 1.80
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res (1992) 1.69
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem (2007) 1.68
C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci (2000) 1.67
Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A (1998) 1.66
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem (1995) 1.65
Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem (1995) 1.65
Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol (1991) 1.61
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord (2009) 1.58
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis (2010) 1.54
Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann N Y Acad Sci (2000) 1.46
Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology (1988) 1.44
Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis (2010) 1.41
High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol (2006) 1.31
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res (1992) 1.30
Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem (2006) 1.26
Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord (2011) 1.21
Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol (2005) 1.19
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol (2007) 1.18
Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett (1995) 1.18
Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. J Neurosci Res (2006) 1.17
Role of metal dyshomeostasis in Alzheimer's disease. Metallomics (2011) 1.12
The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat. Toxicology (1996) 1.11
The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med (2002) 1.11
Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev (1998) 1.08
Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res (1998) 1.08
Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci (1994) 1.07
Animal models of Alzheimer's disease: therapeutic implications. J Alzheimers Dis (2008) 1.06
Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem (1991) 1.06
The effect of formalin fixation on the levels of brain transition metals in archived samples. Biometals (2010) 1.05
Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases. Drugs (1999) 1.05
Ferritin: isolation of aluminum-ferritin complex from brain. Proc Natl Acad Sci U S A (1987) 1.04
Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis (2008) 1.02
Iron up-modulates the expression of transferrin receptors during monocyte-macrophage maturation. J Biol Chem (1989) 1.02
Iron regulatory proteins as NO signal transducers. Sci STKE (2003) 1.01
Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med (2010) 0.99
Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler (2007) 0.95
Metal and inflammatory targets for Alzheimer's disease. Curr Drug Targets (2004) 0.95
Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res (1996) 0.94
Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int (1996) 0.94
Iron: a new target for pharmacological intervention in neurodegenerative diseases. Semin Pediatr Neurol (2006) 0.93
Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. Free Radic Biol Med (1992) 0.93
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radic Biol Med (2002) 0.92
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? Expert Rev Neurother (2007) 0.90
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells. J Neurochem (2008) 0.89
Redox metals in Alzheimer's disease. Ann N Y Acad Sci (2004) 0.88
Coordination chemistry and biology of chelators for the treatment of iron overload disorders. Dalton Trans (2007) 0.87
Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort. Fam Med (2005) 0.87
Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease. Brain Res (1992) 0.87
Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Neurosurgery (1997) 0.85
Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine. Res Exp Med (Berl) (2000) 0.85
Brain inflammation, cholesterol, and glutamate as interconnected participants in the pathology of Alzheimer's disease. Curr Pharm Des (2006) 0.85
Heme oxygenase-1 induction and dependent increase in ferritin. A protective antioxidant stratagem in hemin-treated rat brain. Dev Neurosci (2002) 0.85
A potential pathogenetic role of iron in Alzheimer's disease. J Cell Mol Med (2008) 0.82
The transport of two iron chelators, desferrioxamine B and L1, across Caco-2 monolayers. Br J Haematol (1994) 0.81
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies. J Neuropathol Exp Neurol (2011) 0.80
Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1). J Surg Res (1997) 0.79
Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship. Cell Res (2010) 0.77
Iron, type 2 diabetes mellitus, and Alzheimer's disease. Cell Mol Life Sci (2009) 0.76
Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol (2011) 1.80
Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (2010) 1.78
High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol (2006) 1.31
The STRA6 receptor is essential for retinol-binding protein-induced insulin resistance but not for maintaining vitamin A homeostasis in tissues other than the eye. J Biol Chem (2013) 1.31
Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem (2006) 1.26
Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging (2010) 1.25
Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis (2009) 1.22
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation (2008) 1.22
Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J Alzheimers Dis (2010) 1.10
The effect of formalin fixation on the levels of brain transition metals in archived samples. Biometals (2010) 1.05
Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener (2009) 1.05
Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus. PLoS One (2011) 1.02
A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation. J Biol Chem (2010) 1.02
Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis (2008) 1.02
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis (2010) 1.01
Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels. Hippocampus (2008) 1.00
Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med (2010) 0.99
Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J Alzheimers Dis (2012) 0.98
Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus. Mol Neurodegener (2011) 0.96
The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol (2010) 0.94
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. Proteomics (2012) 0.93
Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. J Neurochem (2008) 0.93
The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis (2010) 0.92
Broad DNA repair responses in neural injury are associated with activation of the IL-6 pathway in cholesterol-fed rabbits. J Neurochem (2009) 0.92
Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins. J Proteome Res (2012) 0.91
Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol. Cell Signal (2011) 0.91
Quantification of punctate iron sources using magnetic resonance phase. Magn Reson Med (2010) 0.90
Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? Neurobiol Aging (2002) 0.89
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol (2011) 0.89
Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. J Alzheimers Dis (2010) 0.88
Leptin signaling and Alzheimer's disease. Am J Neurodegener Dis (2012) 0.88
Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Dis Assoc Disord (2008) 0.88
Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci Lett (2007) 0.87
Aluminum-induced dendritic pathology revisited: cytochemical and electron microscopic studies of rabbit cortical pyramidal neurons. Ann Clin Lab Sci (2002) 0.87
Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease. J Alzheimers Dis (2011) 0.87
Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells. PLoS One (2013) 0.87
Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. J Alzheimers Dis (2006) 0.86
Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease. Mech Ageing Dev (2008) 0.85
Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease. J Alzheimers Dis (2006) 0.85
Five years' world experience with nonpenetrating clips for vascular anastomoses. Am J Surg (2004) 0.85
β-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway. J Neurochem (2010) 0.85
Expanding use of nonpenetrating clips in various surgical specialities. Surg Technol Int (2005) 0.85
Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease. Neurobiol Dis (2011) 0.85
Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem (2003) 0.85
Peri-nuclear clustering of mitochondria is triggered during aluminum maltolate induced apoptosis. J Alzheimers Dis (2006) 0.85
Iron quantification of microbleeds in postmortem brain. Magn Reson Med (2010) 0.84
From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev (2013) 0.83
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.82
Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain. Brain Res (2007) 0.82
Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis. Am J Physiol Regul Integr Comp Physiol (2008) 0.81
The neuroprotective effect of fisetin in the MPTP model of Parkinson's disease. J Parkinsons Dis (2012) 0.81
Iron regulatory protein 2 is involved in brain copper homeostasis. J Alzheimers Dis (2009) 0.80
Aluminum maltolate-induced toxicity in NT2 cells occurs through apoptosis and includes cytochrome c release. Neurotoxicology (2004) 0.80
Targeted glycomics by selected reaction monitoring for highly sensitive glycan compositional analysis. Proteomics (2012) 0.79
A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy. Brain Pathol (2012) 0.79
A multicenter study of permanent hemodialysis access patency: beneficial effect of clipped vascular anastomotic technique. J Vasc Surg (2003) 0.78
Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment. J Alzheimers Dis (2012) 0.78
Mild cognitive impairment: prodromal Alzheimer's disease or something else? J Alzheimers Dis (2011) 0.77
In vivo iron quantification in collagenase-induced microbleeds in rat brain. Magn Reson Med (2011) 0.77
Immunophenotypes in the circulation of patients with mild cognitive impairment. J Psychiatr Res (2007) 0.77
Cerebral Microhemorrhages and Meningeal Siderosis in Infective Endocarditis. Cerebrovasc Dis (2016) 0.77
Cellular model of Alzheimer's disease--relevance to therapeutic testing. Exp Neurol (2011) 0.77
Can studies of aluminum toxicity in vivo and in vitro provide relevant information on the pathogenesis and etiology of Alzheimer's disease? J Alzheimers Dis (2007) 0.76
Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells. Curr Eye Res (2013) 0.75
Supplementation of the diet with silicic acid to reduce body burden of aluminum: a miracle cure or useless treatment for Alzheimer's disease? J Alzheimers Dis (2006) 0.75
Susceptibility-Weighted Magnetic Resonance Imaging in the Evaluation of Dementia. Radiol Case Rep (2015) 0.75
Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. J Alzheimers Dis (2012) 0.75
Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation. J Alzheimers Dis (2017) 0.75
Evolution of staples and clips for vascular anastomoses. Int Surg (2004) 0.75
Tribute to Professor Sun Lee-Experimental Microsurgery Pioneer. Ann Plast Surg (2016) 0.75